The allegations are reminiscent of One Flew Over the Cuckoo's Nest. Gwen Hughes, the former nursing director, is reported to have ordered staff to inject numerous residents with powerful, dangerous antipsychotic medications without any medical justification. According to the charges, groups of staff held down at least two residents and injected them with drugs that reduced them to a zombie-like state. In addition to the three deaths, other residents suffered severe medical and psychological trauma. When drugging triggered behavioral problems, even stronger drugs were ordered and administered. Many residents and family members were not informed that psychoactive drugs were being used.
The year-long investigation by the Attorney General's office was triggered by a Department of Public Health investigation in January 2007 that first documented the widespread drugging and brought a rare finding of "Immediate Jeopardy."
"These people maliciously violated the trust of their patients, by holding them down and forcibly administering psychotropic medications if they dared to question their care," Attorney General Brown said. "This is appalling behavior, which amounts to assault with a deadly weapon."
"Deadly weapon" is an apt description of antipsychotic drugs when used in this fashion. The U.S. Food & Drug Administration (FDA) has issued its most dire warning – known as a black box warning – that antipsychotic drugs cause elders with dementia to die. Although the FDA has never approved use of antipsychotic drugs to treat dementia, it is estimated that up to 40 percent of nursing home residents with dementia are subjected to antipsychotic drugs, such as Zyprexa, Seroquel, Risperdal and Haldol.
The Attorney General's action closely follows a landmark settlement by the U.S. Department of Justice (DOJ) on January 15, 2009 of criminal and civil charges against Eli Lilly for illegally marketing Zyprexa to doctors for unapproved use by elders and children. The company agreed to pay a record $1.415 billion in criminal and civil penalties.
The U.S. DOJ accused Eli Lilly of targeting its illegal marketing of Zyprexa to doctors who treat the elderly in nursing homes and assisted living facilities. According to DOJ, Eli Lilly did so despite lack of FDA approval for this purpose and known severe side effects for this population. Reportedly, Eli Lilly promoted use of Zyprexa by claiming it would help facilities sedate residents who would otherwise require more care.



My client, who also happens to be my brother-in -laws Mom, is a nurse and now a patient. He can't believe that the rehab staff keeps ignoring her and his complaints about how the covering for her colon wound is misapplied, causing her to leak feces into her bed. I have the pictures showing how they put the mitts and even one time a respirator on her to keep her quiet. Why can't they simply change the facility, if they are not satisfied? This is the only one covered by her HMO.
Posted by: Caryn Isaacs | Thursday, June 11, 2009 at 12:40 PM
Chemical restraints are cheaper than the good old fashioned solution to resident care needs: sufficient staff. Thanks for keeping us apprised, Jack.
Posted by: Law Office of Jonathan Ginsberg, LLC | Wednesday, June 10, 2009 at 08:42 AM
This is amazing, Jack. I'm linking from my blog. You are a real champion.
Carol Bradley Bursack
Minding Our Elders
Posted by: Carol Bradley Bursack | Tuesday, May 19, 2009 at 11:15 AM